These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31417361)

  • 1. Cellular Prion Protein as a Receptor of Toxic Amyloid-β42 Oligomers Is Important for Alzheimer's Disease.
    Zhang Y; Zhao Y; Zhang L; Yu W; Wang Y; Chang W
    Front Cell Neurosci; 2019; 13():339. PubMed ID: 31417361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextran sulfate sodium inhibits amyloid-β oligomer binding to cellular prion protein.
    Aimi T; Suzuki K; Hoshino T; Mizushima T
    J Neurochem; 2015 Aug; 134(4):611-7. PubMed ID: 25963375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a
    Younan ND; Chen KF; Rose RS; Crowther DC; Viles JH
    J Biol Chem; 2018 Aug; 293(34):13090-13099. PubMed ID: 29887525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease and prion protein.
    Zhou J; Liu B
    Intractable Rare Dis Res; 2013 May; 2(2):35-44. PubMed ID: 25343100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer's Disease.
    Kong C; Xie H; Gao Z; Shao M; Li H; Shi R; Cai L; Gao S; Sun T; Li C
    Virol Sin; 2019 Oct; 34(5):475-488. PubMed ID: 31093882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β.
    Iida M; Mashima T; Yamaoki Y; So M; Nagata T; Katahira M
    FEBS J; 2019 Jun; 286(12):2355-2365. PubMed ID: 30916478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aβ induces its own prion protein N-terminal fragment (PrPN1)-mediated neutralization in amorphous aggregates.
    Béland M; Bédard M; Tremblay G; Lavigne P; Roucou X
    Neurobiol Aging; 2014 Jul; 35(7):1537-48. PubMed ID: 24602510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
    Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
    Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Sträussler-Scheinker syndrome P102L mutation complicated with dementia.
    Ishizawa K; Komori T; Shimazu T; Yamamoto T; Kitamoto T; Shimazu K; Hirose T
    Acta Neuropathol; 2002 Oct; 104(4):342-50. PubMed ID: 12200619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential Recruitment of Conformationally Distinct Amyloid-β Oligomers by the Intrinsically Disordered Region of the Human Prion Protein.
    Madhu P; Mukhopadhyay S
    ACS Chem Neurosci; 2020 Jan; 11(1):86-98. PubMed ID: 31808343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease.
    Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity.
    Smith LM; Strittmatter SM
    Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 27940601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.